澳大利亚拒绝美国的药品关税, 以保护其负担得起的医疗计划. Australia rejects US drug tariffs to protect its affordable medicine scheme.

尽管美国对进口药品征收了新的关税, 但澳大利亚仍坚持其制药福利计划 (PBS). Australia stands firm on its Pharmaceutical Benefits Scheme (PBS) despite new U.S. tariffs on imported drugs. 卫生部长马克·巴特勒说, 该国不会在计划的核心原则上妥协, 这确保了负担得起的处方药. Health Minister Mark Butler says the country will not compromise on the program's core principles, which ensure affordable access to prescription medicines. 虽然关税针对药品出口,但血产品是澳大利亚生物技术公司CSL的关键产品. While the tariffs target pharmaceutical exports, blood plasma products—key to Australian biotech firm CSL—are exempt. 政府正在评估对出口商的影响, 反对派领导人敦促努力确保进一步豁免. The government is assessing the impact on exporters, and opposition leaders urge efforts to secure further exemptions.